Skip to main content

Closed

KLRA: Kailera Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-24.5%

Financially safe

Stretched

Debt / equity-0.03×

Interest coverage0.0×

Current ratio12.01×

Kailera Therapeutics, Inc.

KLRANASDAQ Global Select·USD·Closed

Kailera Therapeutics, Inc.

KLRANASDAQ·USD·Closed

$16.94

−0.65%

$16.94

−$0.11 (0.65%)

52W Range

5thpctl

Volume

0.59×avg

Mkt Cap

2.19BUSD

P/E

-13.4TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.59×avg

Market Cap

2.19BUSD

P/E Ratio

-13.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings